OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
129 hedge funds and large institutions have $579M invested in Orexigen Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 41 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% less call options, than puts
Call options by funds: $11.7M | Put options by funds: $11.7M
4% less capital invested
Capital invested by funds: $605M → $579M (-$25.5M)
Holders
129
Holding in Top 10
1
Calls
$11.7M
Puts
$11.7M
Top Buyers
| 1 | +$18.6M | |
| 2 | +$13.3M | |
| 3 | +$5.55M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.26M |
| 5 |
CC
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
+$4.08M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$8.65M | |
| 3 | -$8.6M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$5.1M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.24M |